The ADC PB-vcMMAE-5 was administered intravenously at doses 1, 3, 6 or 9 mg/kg, once per week for five weeks. On day 31 from the first ADC infusion, most alive mice were sacrificed, and tumors were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback